Stock Scorecard
Stock Summary for Resmed Inc (RMD) - $255.80 as of 11/26/2025 3:34:22 PM EST
Total Score
20 out of 30
Safety Score
65 out of 100
Currently on the following lists
Dividend Stock List
Tim's Recommendation
Buy
Growth List Algorithm Criteria for RMD
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RMD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RMD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for RMD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for RMD (65 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 7 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 6 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for RMD
Financial Details for RMD
Company Overview |
|
|---|---|
| Ticker | RMD |
| Company Name | Resmed Inc |
| Country | USA |
| Description | ResMed Inc. (RMD) is a leading healthcare technology company based in San Diego that specializes in cloud-connected devices and software for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The company is dedicated to elevating patient outcomes through cutting-edge digital health innovations while streamlining clinical effectiveness and operational efficiencies for healthcare providers. As a pioneer in the respiratory care sector, ResMed is well-positioned for significant growth, underpinned by its strategic global market expansion and the rising demand for integrated respiratory solutions among patients worldwide. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL INSTRUMENTS & SUPPLIES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 1/22/2026 |
Stock Price History |
|
| Last Day Price | 255.80 |
| Price 4 Years Ago | 251.31 |
| Last Day Price Updated | 11/26/2025 3:34:22 PM EST |
| Last Day Volume | 812,363 |
| Average Daily Volume | 1,252,326 |
| 52-Week High | 293.11 |
| 52-Week Low | 198.60 |
| Last Price to 52 Week Low | 28.80% |
Valuation Measures |
|
| Trailing PE | 25.64 |
| Industry PE | 408.09 |
| Sector PE | 88.38 |
| 5-Year Average PE | 45.31 |
| Free Cash Flow Ratio | 26.98 |
| Industry Free Cash Flow Ratio | 40.57 |
| Sector Free Cash Flow Ratio | 28.18 |
| Current Ratio Most Recent Quarter | 2.89 |
| Total Cash Per Share | 9.48 |
| Book Value Per Share Most Recent Quarter | 41.94 |
| Price to Book Ratio | 5.98 |
| Industry Price to Book Ratio | 3.45 |
| Sector Price to Book Ratio | 32.98 |
| Price to Sales Ratio Twelve Trailing Months | 6.96 |
| Industry Price to Sales Ratio Twelve Trailing Months | 47.67 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.65 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 145,966,000 |
| Market Capitalization | 37,338,102,800 |
| Institutional Ownership | 65.62% |
Dividends |
|
| Ex-Dividend Date | 11/13/2025 |
| Previous Dividend Amount | 0.6000 |
| Current Dividend Amount | 0.6000 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 2.26 |
| Trailing Annual Dividend Yield | 0.88% |
| Forward Annual Dividend Rate | 2.40 |
| Forward Annual Dividend Yield | 0.94% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.99% |
| 5-Year Average Dividend Yield | 0.87% |
| 1-Year Dividend Growth Rate Percentage | 11.88% |
| 3-Year Dividend Growth Rate Percentage | 10.83% |
| 5-Year Dividend Growth Rate Percentage | 8.68% |
| All-Time Dividend Growth Rate Percentage | 8.60% |
| Dividend Payout Ratio | 23.13% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 12.30% |
| Annual Earnings Growth | 37.20% |
| Reported EPS 12 Trailing Months | 9.77 |
| Reported EPS Past Year | 2.55 |
| Reported EPS Prior Year | 9.55 |
| Net Income Twelve Trailing Months | 1,437,904,000 |
| Net Income Past Year | 1,400,723,000 |
| Net Income Prior Year | 1,020,951,000 |
| Quarterly Revenue Growth YOY | 9.10% |
| 5-Year Revenue Growth | 11.72% |
| Operating Margin Twelve Trailing Months | 34.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,383,848,000 |
| Total Cash Past Year | 1,209,450,000 |
| Total Cash Prior Year | 238,361,000 |
| Net Cash Position Most Recent Quarter | 975,187,000 |
| Net Cash Position Past Year | 551,058,000 |
| Long Term Debt Past Year | 658,392,000 |
| Long Term Debt Prior Year | 697,313,000 |
| Total Debt Most Recent Quarter | 408,661,000 |
| Equity to Debt Ratio Past Year | 0.90 |
| Equity to Debt Ratio Most Recent Quarter | 0.94 |
| Total Stockholder Equity Past Year | 5,967,859,000 |
| Total Stockholder Equity Prior Year | 4,864,043,000 |
| Total Stockholder Equity Most Recent Quarter | 6,121,264,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,767,156,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 12.11 |
| Free Cash Flow Past Year | 1,661,723,000 |
| Free Cash Flow Prior Year | 1,286,404,000 |
Options |
|
| Put/Call Ratio | 0.86 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -5.70 |
| MACD Signal | -5.87 |
| 20-Day Bollinger Lower Band | 240.20 |
| 20-Day Bollinger Middle Band | 267.36 |
| 20-Day Bollinger Upper Band | 294.52 |
| Beta | 0.87 |
| RSI | 32.73 |
| 50-Day SMA | 247.65 |
| 150-Day SMA | 214.58 |
| 200-Day SMA | 215.15 |
System |
|
| Modified | 11/25/2025 7:55:55 AM EST |